Due to the different results among TNBC and non-TNBC cells as well as among TNBC subtypes, we found vague evidence, in which mechanisms caused proliferation inhibition in breast cancer cells by the PD-1/PD-L1 and ERK1/2 inhibitor. The gene discussed is PDCD1; the disease is breast carcinoma.